TRIM24 and breast carcinoma: High levels of TRIM24 expression are also associated with poorer prognoses in patients with breast cancer [105,106], although whether this can be ascribed to p53 suppression by TRIM24 remains unclear, as TRIM24 interacts with estrogen receptors and activates downstream pathways [105,106,107].